Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600118397Phase 4Not yet recruiting
Phase 4, randomised trial in gastrointestinal neoplasia comparing Fospropofol disodium arm with Propofol arm (2 arms). Primary endpoint: Postoperative delirium incidence. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600118397.